首页> 外文OA文献 >Medium-Dose Indacaterol/Glycopyrronium/Mometasone Furoate Fixed-Dose Combination Improves Lung Function Compared with High-Dose Indacaterol/Mometasone Furoate and Salmeterol/Fluticasone and Reduces Exacerbation Rates Versus High-Dose Salmeterol/Fluticasone in Moderate-to-Severe Asthma: The IRIDIUM Study

【2h】

Medium-Dose Indacaterol/Glycopyrronium/Mometasone Furoate Fixed-Dose Combination Improves Lung Function Compared with High-Dose Indacaterol/Mometasone Furoate and Salmeterol/Fluticasone and Reduces Exacerbation Rates Versus High-Dose Salmeterol/Fluticasone in Moderate-to-Severe Asthma: The IRIDIUM Study

机译：中剂量茚钒/甘油酮/米多酮呋喃固定剂组合改善了肺功能与高剂量茚钒/米多酮呋喃（Salmeterol / Fluticason）相比，并降低了中度至严重的哮喘中的高剂量Salmeterol /氟替卡松的恶化率：铱学习

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
引文网络
相似文献
相关主题

著录项

作者
A. Papi; M. Humbert; K. Kostikas; C. Domingo; J.F. Maspero; M. Hosoe; A.-M. Tanase; A. Pethe; X. Shu; P. D’Andrea;
展开▼
作者单位

展开▼
年度 2020
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献

1. Indacaterol acetate/mometasone furoate provides sustained improvements in lung function compared with salmeterol xinafoate/fluticasone propionate in patients with moderate-to-very-severe COPD: results from a Phase II randomized, double-blind 12-week study [J] . Kai Michael Beeh, Anne-Marie Kirsten, Ana-Maria Tanase, International Journal of Chronic Obstructive Pulmonary Disease . 2018,第1期

机译：与中度至非常重度COPD患者相比，醋酸茚达特罗/糠酸莫美他松与沙美特罗新萘甲酸/丙酸氟替卡松相比，肺功能持续改善：II期随机，双盲12周研究的结果
2. INDACATEROL/GLYCOPYRRONIUM (IND/GLY) REDUCES EXACERBATION AND IMPROVES LUNG FUNCTION VERSUS SALMETEROL/FLUTICASONE (SFC) IN PATIENTS WITH AND WITHOUT PRIOR ICS USE: THE FLAME STUDY [J] . Patalano Francesco, Wedzicha Jadwiga A., Vestbo Jorgen, Respirology : . 2017,第Suppla2期

机译：吲哚替莫特/糖酮（IND / GLY）减少加剧，并改善肺功能与Salmeterol /氟替卡松（SFC）的患者，无需先前ICS使用：火焰研究
3. Risk of Asthma Exacerbation, Asthma-Related Health Care Utilization and Costs, and Adherence to Controller Therapy in Patients with Asthma Receiving Fluticasone Propionate/Salmeterol Inhalation Powder 100 μg/50 μg Versus Mometasone Furoate Inhalation Powder [J] . HagiwaraM., DeleaT.E., StanfordR.H. The journal of asthma . 2013,第3期

机译：接受丙酸氟替卡松/沙美特罗吸入粉的哮喘患者的哮喘加重风险，与哮喘有关的医疗保健和费用以及坚持控制治疗的风险100μg/ 50μg与莫米松酮富尿酸盐吸入粉相比
4. Letter to the editor: indacaterol/glycopyrronium/mometasone furoate compared with salmeterol/fluticasone propionate in patients with asthma: a randomized controlled cross-over study [O] . Henrik Watz, Jens M. Hohlfeld, Dave Singh, 2020

机译：致编辑的信：哮喘患者中茚达特罗/格隆铵/糠酸莫美他松与沙美特罗/丙酸氟替卡松的比较：一项随机对照研究
5. Indacaterol/Mometasone Furoate Fixed-Dose Combination Improves Lung Function and Decreases Exacerbations Compared with Salmeterol/Fluticasone in Patients with Uncontrolled Asthma: Pooled Analyses of PALLADIUM and IRIDIUM Studies [O] . K.R. Chapman, R. van Zyl-Smit, H.A.M. Kerstjens, 2020

机译：吲哚替昔酚/米多酮呋喃固定剂组合改善肺功能，与患有不受控制的哮喘患者的Salmeterol /氟碳松相比，降低了恶化：钯和铱研究的汇总分析

著录项

引文网络

相似文献

相关主题

期刊订阅